XOMA Royalty Corp. (XOMA)

25.86 +0.37 (+1.45%) USD  |  NASDAQ  |  Dec 16, 16:00
26.00 +0.14 (+0.54%) After-Hours: 20:00
More

XOMA Royalty Research and Development Expense (Annual): 2.875M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for XOMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Mural Oncology Plc 109.37M
Rezolute, Inc. 61.53M
Vistagen Therapeutics, Inc. 39.38M
Zevra Therapeutics, Inc. 35.71M
DiaMedica Therapeutics, Inc. 19.06M